BROWSE ALL ARTICLES BY TOPIC
EXCLUSIVE ONLINE ARTICLES
Listing articles 1 to 10 of 85
The Hospital for Special Surgery Division of Rheumatology held an event “Honoring Lupus Heroes” as part of its 150th anniversary celebration. (posted Nov. 26)
In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage. (posted Nov. 19)
A new study suggests that GATM may serve as the functional link between the ability of statins to lower cholesterol and their ability to cause statin-induced myopathy. (posted Nov. 19)
Patients with acute pericarditis who are treated with colchicine in combination with a traditional antiinflammatory therapy experience a significantly reduced rate of incessant or recurrent pericarditis.
The “RA in America 2013" survey estimates out-of-pocket cost for RA treatment at $1,000 to $5,000 per year.
Although HHS reports no significant changes in Medicare participation for office-based physicians, the numbers may be misleading. (posted Oct. 16, 2013)
Chondrocyte telomere length might play a role in the natural aging of cartilage, as well as the development and progression of OA. (posted Oct. 8, 2013)
A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)
The recent U.S. Supreme Court decision that ruled human genes cannot be patented may provide greater access to genetic testing. (posted Sept. 24, 2013)
The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)